1.Inhibition of intimal hyperplasia by local perivascular application of rapamycin and imatinib mesilate after carotid balloon injury.
Daedo PARK ; Suh Min KIM ; Sang Il MIN ; Jongwon HA ; In Gyu KIM ; Seung Kee MIN
Journal of the Korean Surgical Society 2013;85(6):296-301
PURPOSE: Inhibition of the intimal hyperplasia after vascular surgery is an important issue. The purpose of this study is to define whether perivascular application of rapamycin, imatinib mesylate or cysteamine can reduce intimal hyperplasia in a carotid balloon injury model. METHODS: Each drug was mixed with 40% pluronic gel solution and was topically applied over the injured carotid artery evenly. Two or four weeks after injury, the arteries were harvested and morphometric analysis was done. RESULTS: The medial areas were not significantly different in each group and a thinning of the media as a toxic drug effect was not observed in any treatment group. The intimal area and intima-to-media (I/M) ratio were significantly reduced in rapamycin-treated group and imatinib-treated group (P < 0.05). But cysteamine-treated group showed a trend of decrease in I/M ratio in 2 weeks, but no difference in 4 weeks. CONCLUSION: Perivascular delivery of imatinib or rapamycin with pluronic gel attenuated the development of intimal hyperplasia. But cysteamine did not. Further studies are needed to refine the optimal drug dosages in large animal models.
Arteries
;
Benzamides
;
Carotid Arteries
;
Carotid Artery Injuries
;
Cysteamine
;
Hyperplasia*
;
Imatinib Mesylate
;
Mesylates*
;
Models, Animal
;
Piperazines
;
Pyrimidines
;
Sirolimus*
2.Comparison of Costs of Endovascular Repair versus Open Surgical Repair for Abdominal Aortic Aneurysm in Korea.
Sang Il MIN ; Seung Kee MIN ; Sanghyun AHN ; Suh Min KIM ; Daedo PARK ; Taejin PARK ; Jin Wook CHUNG ; Jae Hyung PARK ; Jongwon HA ; Sang Joon KIM ; In Mok JUNG
Journal of Korean Medical Science 2012;27(4):416-422
This study was designed to compare the hospital-related costs of elective abdominal aortic aneurysm (AAA) treatment and cost structure between endovascular aneurysm repair (EVAR) and open surgical repair (OSR) in Korean health care system. One hundred five primary elective AAA repairs (79 OSRs and 26 EVARs) performed in the Seoul National University Hospital from 2005 to 2009 were included. Patient characteristics were similar between two groups except for older age (P = 0.004) and more frequent history of malignancy (P = 0.031) in EVAR group. Thirty-day mortality rate was similar between two groups and there was no AAA-related mortality in both groups for 5 yr after repair. The total in-hospital costs for the index admission were significantly higher in EVAR patients (mean, KRW19,857,119) than OSR patients (mean KRW12,395,507) (P < 0.001). The reimbursement was also significantly higher in EVAR patients than OSR patients (mean, KRW14,071,081 vs KRW6,238,895, P < 0.001) while patients payments was comparable between two groups. EVAR patients showed higher follow-up cost up to 2 yr due to more frequent imaging studies and reinterventions for type II endoleaks (15.4%). In the perspective of cost-effectiveness, this study suggests that the determination of which method to be used in AAA treatment be more finely trimmed and be individualized.
Aged
;
Aged, 80 and over
;
Aortic Aneurysm, Abdominal/economics/mortality/*surgery
;
Blood Vessel Prosthesis Implantation/*economics
;
Cost-Benefit Analysis
;
Endoleak
;
Female
;
Follow-Up Studies
;
Humans
;
Insurance, Health, Reimbursement
;
Magnetic Resonance Angiography
;
Male
;
Middle Aged
;
Republic of Korea
;
Survival Analysis
;
Treatment Outcome
;
Vascular Surgical Procedures/*economics
3.Clinical Significance of Protocol Biopsy Soon after Renal Transplantation.
Seung Young OH ; Sang Il MIN ; Sanghyun AHN ; Suh Min KIM ; Daedo PARK ; Taejin PARK ; Kyung Chul MOON ; Jongwon HA ; Sang Joon KIM
The Journal of the Korean Society for Transplantation 2011;25(4):264-269
BACKGROUND: Several studies reported that sub-clinical rejection (SCR) detected by a protocol biopsy soon after renal transplantation does permanent damage to a renal allograft, contributing to chronic allograft nephropathy (CAN). This article investigated the risk factors involved in SCR and the effects of treating SCR, and evaluated the clinical significance of a protocol biopsy soon after renal transplantation. METHODS: From January 2007 to June 2010, 253 patients received renal transplantation. Patients were divided into two groups according to whether or not they had undergone a protocol biopsy. To analyze the effect of SCR treatments, patients who were diagnosed with SCR were divided into two groups according to whether or not they had been treated with SCR. The patients who did not undertake a protocol biopsy were included in the untreated groups. RESULTS: Among 138 patients who undertook protocol biopsies, 65 patients (47.1%) showed SCR. In univariate analysis, both the number of HLA-DR mismatches (P=0.003) and not using Simulect (P=0.01) were identified as risk factors of SCR. In multivariate analysis, not using Simulect (P=0.006) was identified as an risk factor independent of SCR. deltaGFR, subtracting GFR at 1 week from GFR at that point, showed significant differences between SCR-treated patients and untreated patients at 1, 3, 6, 9, 12, 24, and 36 months with a P value of less than 0.05. CONCLUSIONS: A protocol biopsy can detect SCR, especially in patients with risk factors such as a high number of HLA mismatches or not using Simulect. Treatment of SCR detected by protocol biopsy will help to improve long-term renal function.
Antibodies, Monoclonal
;
Biopsy
;
HLA-DR Antigens
;
Humans
;
Kidney Transplantation
;
Multivariate Analysis
;
Recombinant Fusion Proteins
;
Rejection (Psychology)
;
Risk Factors
;
Transplantation, Homologous
4.Clinical Significance of Protocol Biopsy Soon after Renal Transplantation.
Seung Young OH ; Sang Il MIN ; Sanghyun AHN ; Suh Min KIM ; Daedo PARK ; Taejin PARK ; Kyung Chul MOON ; Jongwon HA ; Sang Joon KIM
The Journal of the Korean Society for Transplantation 2011;25(4):264-269
BACKGROUND: Several studies reported that sub-clinical rejection (SCR) detected by a protocol biopsy soon after renal transplantation does permanent damage to a renal allograft, contributing to chronic allograft nephropathy (CAN). This article investigated the risk factors involved in SCR and the effects of treating SCR, and evaluated the clinical significance of a protocol biopsy soon after renal transplantation. METHODS: From January 2007 to June 2010, 253 patients received renal transplantation. Patients were divided into two groups according to whether or not they had undergone a protocol biopsy. To analyze the effect of SCR treatments, patients who were diagnosed with SCR were divided into two groups according to whether or not they had been treated with SCR. The patients who did not undertake a protocol biopsy were included in the untreated groups. RESULTS: Among 138 patients who undertook protocol biopsies, 65 patients (47.1%) showed SCR. In univariate analysis, both the number of HLA-DR mismatches (P=0.003) and not using Simulect (P=0.01) were identified as risk factors of SCR. In multivariate analysis, not using Simulect (P=0.006) was identified as an risk factor independent of SCR. deltaGFR, subtracting GFR at 1 week from GFR at that point, showed significant differences between SCR-treated patients and untreated patients at 1, 3, 6, 9, 12, 24, and 36 months with a P value of less than 0.05. CONCLUSIONS: A protocol biopsy can detect SCR, especially in patients with risk factors such as a high number of HLA mismatches or not using Simulect. Treatment of SCR detected by protocol biopsy will help to improve long-term renal function.
Antibodies, Monoclonal
;
Biopsy
;
HLA-DR Antigens
;
Humans
;
Kidney Transplantation
;
Multivariate Analysis
;
Recombinant Fusion Proteins
;
Rejection (Psychology)
;
Risk Factors
;
Transplantation, Homologous
5.Reconstruction of portal vein and superior mesenteric vein after extensive resection for pancreatic cancer.
Suh Min KIM ; Seung Kee MIN ; Daedo PARK ; Sang Il MIN ; Jin Young JANG ; Sun Whe KIM ; Jongwon HA ; Sang Joon KIM
Journal of the Korean Surgical Society 2013;84(6):346-352
PURPOSE: Tumor invasion to the portal vein (PV) or superior mesenteric vein (SMV) can be encountered during the surgery for pancreatic cancer. Venous reconstruction is required, but the optimal surgical methods and conduits remain in controversies. METHODS: From January 2007 to July 2012, 16 venous reconstructions were performed during surgery for pancreatic cancer in 14 patients. We analyzed the methods, conduits, graft patency, and patient survival. RESULTS: The involved veins were 14 SMVs and 2 PVs. The operative methods included resection and end-to-end anastomosis in 7 patients, wedge resection with venoplasty in 2 patients, bovine patch repair in 3 patients, and interposition graft with bovine patch in 1 patient. In one patient with a failed interposition graft with great saphenous vein (GSV), the SMV was reconstructed with a prosthetic interposition graft, which was revised with a spiral graft of GSV. Vascular morbidity occurred in 4 cases; occlusion of an interposition graft with GSV or polytetrafluoroethylene, segmental thrombosis and stenosis of the SMV after end-to-end anastomosis. Patency was maintained in patients with bovine patch angioplasty and spiral vein grafts. With mean follow-up of 9.8 months, the 6- and 12-month death-censored graft survival rates were both 81.3%. CONCLUSION: Many of the involved vein segments were repaired primarily. When tension-free anastomosis is impossible, the spiral grafts with GSV or bovine patch grafts are good options to overcome the size mismatch between autologous vein graft and portomesenteric veins. Further follow-up of these patients is needed to demonstrate long-term patency.
Angioplasty
;
Constriction, Pathologic
;
Follow-Up Studies
;
Graft Survival
;
Humans
;
Mesenteric Veins
;
Pancreatic Neoplasms
;
Pancreaticoduodenectomy
;
Polytetrafluoroethylene
;
Portal Vein
;
Saphenous Vein
;
Thrombosis
;
Transplants
;
Veins
6.Outcomes after Arterial or Venous Reconstructions in Limb Salvage Surgery for Extremity Soft Tissue Sarcoma.
Daedo PARK ; Sungsin CHO ; Ahram HAN ; Chanjoong CHOI ; Sanghyun AHN ; Sang il MIN ; Jongwon HA ; Seung Kee MIN
Journal of Korean Medical Science 2018;33(40):e265-
BACKGROUND: Limb salvage surgery with vascular reconstruction is currently considered as the standard treatment for extremity soft tissue sarcoma (STS), showing equivalent oncologic outcome compared with amputation. In this retrospective study, the surgical and functional outcomes after arterial or venous reconstruction in limb salvage surgery for STS were analyzed. METHODS: Consecutive patients who underwent vascular resection and reconstruction as part of limb salvage surgery for extremity STS from July 2009 to June 2015 were included in this study. Incidence of surgical complication, graft patency, and patients' functional outcome were reviewed. RESULTS: During the study period, 14 arteries and 13 veins were reconstructed in 17 patients (artery only in 4, vein only in 3, artery and vein in 10). Autologous great saphenous vein (GSV) was the most commonly used vascular conduit in both arterial and venous reconstruction (78.6% and 77.0%). The patency of synthetic graft was significantly lower than that of the autologous vein conduit (log rank test, P = 0.001). Among 15 patients with tumors in lower extremity, 13 were ambulatory after limb salvage surgery. During median follow up of 23.3 months (interquartile range 39.9 months), 2 patients (11.7%) needed amputation of the initially salvaged limb due to local recurrence. CONCLUSION: Limb salvage surgery of soft tissue tumor combined with vascular reconstruction showed favorable functional outcome with good local control. Autologous vein conduit is preferred over synthetic graft both in arterial and venous reconstruction.
Amputation
;
Arteries
;
Blood Vessels
;
Extremities*
;
Follow-Up Studies
;
Humans
;
Incidence
;
Limb Salvage*
;
Lower Extremity
;
Recurrence
;
Retrospective Studies
;
Saphenous Vein
;
Sarcoma*
;
Transplants
;
Veins
7.Successful Endovascular Treatment of Delayed Type Ib Endoleak with Aortic Rupture after Endovascular Repair of Abdominal Aortic Aneurysm.
Daedo PARK ; Sang Il MIN ; Hwan Jun JAE ; Jin Wook CHUNG ; Suh Min KIM ; Seung Kee MIN ; Jongwon HA
Journal of the Korean Society for Vascular Surgery 2013;29(4):142-146
Endovascular aneurysm repair (EVAR) has progressively become the preferred method for abdominal aortic aneurysm repair. Controlled studies have indicated that EVAR is related to decreased perioperative morbidity and mortality compared with open repair. However, long-term complications are more common. The most common complication following EVAR is an endoleak. Few studies on delayed type Ib endoleak with aortic rupture have been found in the literature. We report a case of a 92-year-old man with a delayed type Ib endoleak with aortic rupture that developed 7 years after EVAR. Lifelong surveillance after EVAR is mandatory.
Aneurysm
;
Aortic Aneurysm, Abdominal*
;
Aortic Rupture*
;
Endoleak*
;
Mortality
;
Rupture